Related content

Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis

By Emad Yasser   Shehata Mohamed   Ragab Yasser   Saad Ahmed   Hamza Hosny   Abou-Zeid Alaa  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 358-365

Springer Publishing Company

Access to resources Recommend Favorite

The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis

By Xue Y.   Zhang J.   Chen Y-M.   Guan M.   Zheng S. G.   Zou H-J.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 183-187

Informa Healthcare

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite

Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 ( MMP - 13 ) −77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis

By Iwamoto Naoki  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 240-243

Springer Publishing Company

Access to resources Recommend Favorite